NERM
VTRS icon

New England Research & Management’s Viatris VTRS Stock Holding History

New England Research & Management’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,900
Closed -$307K – 178
2017
Q2 		$307K Sell
7,900
-550
-7% -$21.1K 0.23% 125
2017
Q1 		$329K Buy
8,450
+250
+3% +$10.1K 0.25% 121
2016
Q4 		$313K Sell
8,200
-1,750
-18% -$65K 0.25% 130
2016
Q3 		$379K Sell
9,950
-200
-2% -$8.89K 0.32% 108
2016
Q2 		$439K Sell
10,150
-1,975
-16% -$87.4K 0.38% 88
2016
Q1 		$562K Sell
12,125
-50
-0.4% -$2.41K 0.48% 78
2015
Q4 		$658K Sell
12,175
-2,900
-19% -$139K 0.57% 64
2015
Q3 		$607K Buy
15,075
+1,350
+10% +$75.3K 0.58% 65
2015
Q2 		$931K Buy
13,725
+8,550
+165% +$604K 0.76% 43
2015
Q1 		$307K Sell
5,175
-9,315
-64% -$531K 0.26% 127
2014
Q4 		$817K Sell
14,490
-1,875
-11% -$101K 0.7% 50
2014
Q3 		$744K Buy
16,365
+7,475
+84% +$363K 0.65% 64
2014
Q2 		$458K Buy
+8,890
New +$437K 0.41% 102

Other funds holding VTRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

New England Research & Management's VTRS Position: Q3 2017 in Review

New England Research & Management sold out of Viatris (VTRS) in Q3 2017, closing a stake of 7,900 shares — an estimated $307K sold.

New England Research & Management first reported a position in VTRS in Q2 2014 and held it in 13 quarters. The position peaked at $931K in Q2 2015. 472 funds tracked by Wall St. Rank hold VTRS as of Q3 2017.

  • New England Research & Management reported no remaining Viatris position as of Q3 2017 after selling out during the quarter.
  • New England Research & Management sold 7,900 Viatris shares in Q3 2017, an estimated $307K.
  • New England Research & Management first reported a position in Viatris in Q2 2014 and held it in 13 quarters.
  • New England Research & Management's Viatris position peaked at $931K in Q2 2015.
  • 472 funds tracked by Wall St. Rank held Viatris as of Q3 2017.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.